SUSQUEHANNA INTERNATIONAL GROUP, LLP - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q3 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$9,760,000
+81.1%
354,411
+8.4%
0.00%
Q1 2021$5,390,000
-66.4%
326,837
-62.4%
0.00%
-100.0%
Q4 2020$16,034,000
+212.2%
869,964
+130.6%
0.00%
Q3 2020$5,135,000
-7.1%
377,338
+22.3%
0.00%
-100.0%
Q2 2020$5,528,000
+3585.3%
308,475
+1955.1%
0.00%
Q1 2020$150,000
+4.2%
15,010
+3.0%
0.00%
Q3 2019$144,000
-51.0%
14,576
-37.4%
0.00%
Q2 2019$294,00023,2720.00%
Other shareholders
TRANSLATE BIO INC shareholders Q3 2020
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 2,656,517$48,960,00010.98%
Copernicus Capital Management, LLC 12,091$223,0003.48%
FRAZIER MANAGEMENT LLC 2,182,789$40,229,0003.10%
Baupost Group 18,044,239$326,236,0003.01%
DAFNA Capital Management LLC 225,393$4,154,0001.24%
RTW INVESTMENTS, LP 2,978,427$54,892,0000.92%
MARATHON CAPITAL MANAGEMENT 143,275$2,640,0000.78%
Bain Capital Public Equity Management II, LLC 627,387$11,563,0000.59%
Artal Group S.A. 1,200,000$22,116,0000.48%
Birchview Capital, LP 30,000$553,0000.32%
View complete list of TRANSLATE BIO INC shareholders